The bradykinin B1 receptor antagonist R-954 inhibits Ehrlich tumor growth in rodents

Peptides

Volumn 32, Issue 9, 2011, Pages 1849-1854

  Fernandes, Patricia Dias ^a   Gomes, Niele De Matos ^a   Sirois, Pierre ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Bradykinin; Bradykinin B1 antagonist; Cancer; Ehrlich ascitic tumor; R 954

Indexed keywords

BRADYKININ B1 RECEPTOR ANTAGONIST; NITRIC OXIDE; PROSTAGLANDIN E2; R 954; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VINCRISTINE; AC ORN (OIC2, ALPHA MEPHE5, D BETANAL7, ILE8)DESARG9 BRADYKININ; AC-ORN-(OIC2, ALPHA-MEPHE5, D-BETANAL7, ILE8)DESARG9-BRADYKININ; ANTINEOPLASTIC AGENT; AUTACOID; BRADYKININ; BRADYKININ B1 RECEPTOR; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SURVIVAL; TUMOR VOLUME; ANIMAL; ASCITES FLUID; BAGG ALBINO MOUSE; BLOOD CELL COUNT; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EDEMA; EHRLICH ASCITES TUMOR; INFLAMMATION; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WEIGHT GAIN; WISTAR RAT;

MUS; RATTUS; RODENTIA;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCITIC FLUID; BLOOD CELL COUNT; BRADYKININ; CARCINOMA, EHRLICH TUMOR; DINOPROSTONE; EDEMA; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VINCRISTINE; WEIGHT GAIN;

EID: 80052731692     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.07.023     Document Type: Article

References (58)

1. C.E. Austin, J.C. Foreman, and G.K. Scadding Reduction by HOE-140, the B-2 kinin receptor antagonist, of antigen-induced nasal blockage Br J Pharmacol 111 1994 969 971 (Pubitemid 24148754)
2. L.L. Barki-Harrington, and Y. Daaka Bradykinin induced mitogenesis of androgen independent prostate cancer cells J Urol 165 2001 2121 2125
3. L. Barki-Harrington, A.L. Bookout, G. Wang, M.E. Lamb, L.M. Leeb-Lundberg, and Y. Daaka Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells Biochem J 371 2003 581 587 (Pubitemid 36547643)
4. W.T. Beraldo Formation of bradykinin in anaphylactic and peptone shock Am J Physiol 163 1950 283 289
5. P.C. Bergamini-Santos, M. Mariano, and J.A.M. Barbuto Dual role of polymorphonuclear neutrophils on the growth of Ehrlich ascites tumor (EAT) in mice Life Sci 75 2004 245 255 (Pubitemid 38553879)
6. K.D. Bhoola, C.D. Figueroa, and K. Worthy Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol Rev 44 1992 1 80
7. P.A. Bunn, D.C. Chan, D.O. Dienhart, R. Tolly, M. Togawa, and P.B. Jewett Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity Cancer Res 52 1991 24 31
8. D. Chan, L. Gera, J. Stewart, B. Helfrich, M. Verella-Garcia, and G. Johnson Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a biased agonist mechanism Proc Nat Acad Sci USA 99 2002 4608 4613 (Pubitemid 34286032)
9. D. Chan, L. Gera, J. Stewart, B. Helfrich, T.L. Zhao, and W.Y. Feng Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents Clin Cancer Res 8 2002 1280 1287 (Pubitemid 34517669)
10. L. Chen, and J.F. Watkins Evidence against the presence of H2 histocompatibility antigens in Ehrlich ascites tumor cells Nature 225 1970 734 735
11. A.P. Corrado, M.L. Reis, I.F. Carvalho, and C.R. Diniz Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes Biochem Pharmacol 15 1966 959 970
12. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392 (Pubitemid 34270240)
13. A. Dray, and M. Perkins Bradykinin and inflammatory pain Trends Neurosci 16 1993 99 104 (Pubitemid 23048436)
14. J. Fastaia, and A. Dumont Pathogenesis of ascites in mice with peritoneal carcinomatosis J Nat Cancer Inst 56 1976 547 549
15. D. Fecchio, P. Sirois, M. Russo, and S. Jancar Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity Inflammation 14 1990 125 132 (Pubitemid 20061425)
16. S.H. Ferreira A new method for measuring variations of rat paw volume J Pharmacol 31 1979 648 653
17. D.A. Flick, and G.E. Gliford Comparison of in vitro cell cytotoxic assays for tumor necrosis factor J Immunol Methods 68 1984 167 175 (Pubitemid 14133657)
18. A. Gohla, S. Offermanns, T.M. Wilkie, and G. Schultz Differential involvement of G-12 and G-13 in receptor-mediated stress fiber formation J Biol Chem 274 1999 17901 17907
19. N.M. Gomes, C.M. Rezende, S.P. Fontes, A.M.C. Hovell, R.G. Landgraf, and M.E. Matheus Antineoplasic activity of Copaifera multijuga oil and fractions against ascitic and solid Ehrlich tumor J Ethnopharmacol 119 2008 179 184
20. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wisnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1982 131 138 (Pubitemid 13203451)
21. D.E. Hu, and T.P. Fan [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats Br J Pharmacol 109 1993 14 17
22. K. Ishihara, M. Kamata, I. Hayashi, S. Yamashina, and M. Majima Roles of bradykinin in vascular permeability and angiogenesis in solid tumors Int Immunopharmacol 2 2002 499 509 (Pubitemid 34169745)
23. M. Katori, and M. Majima Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship Jpn J Pharmacol 70 1996 95 128 (Pubitemid 26079782)
24. R. Keller, R. Keist, A. Wechsler, T.P. Leist, and P.H. Van der Meide Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor Int J Cancer 46 1990 682 686 (Pubitemid 20355760)
25. A.H. Klimp, E.G.E. de Vries, G.L. Scherphof, and T. Daemen A potential role of macrophage activation in the treatment of cancer Crit Rev Oncol/Hematol 44 2002 143 161 (Pubitemid 36159043)
26. P.F. Kue, J.S. Taub, L. Barki-Harrington, R.D. Polakiewicz, U. Ullrich, and Y. Daaka Lysophosphatidic acid-regulated mitogenic ERK signaling in androgenin sensitive prostate cancer PC-3 cells Int J Cancer 102 2002 572 579 (Pubitemid 35334463)
27. S.R. Lawson, B.H. Gabra, B. Guérin, W. Neugebauer, F. Nantel, and B. Battistini Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist Regul Peptides 124 2005 221 224 (Pubitemid 39488363)
28. H. Maeda, Y. Matsumura, and H. Kato Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer J Biol Chem 263 1988 16051 16054 (Pubitemid 18262016)
29. F. Marceau, and D.R. Bachvarov Kinin receptors Clin Rev Allergy Immunol 16 1998 385 401 (Pubitemid 29056352)
30. F. Marceau, J. Barabé, S. St Pierre, and D. Regoli Kinin receptors in experimental inflammation Can J Physiol Pharmacol 58 1980 536 542 (Pubitemid 10091429)
31. F. Marceau, J.F. Hess, and D.R. Bachvarov The B1 receptors for kinins Pharmacol Rev 50 1988 357 386
32. H.S. Margolius, R.G. Geller, W. De Jong, J.J. Pisano, and A. Sjoerdsma Urinary kallikrein excretion in hypertension Circ Res 31 1972 125 131
33. Y. Matsumura, M. Kimura, T. Yamamoto, and H. Maeda Involvement of the kinin-generating cascade and enhanced vascular permeability in tumor tissue Jpn J Cancer Res 79 1988 1327 1334 (Pubitemid 20019411)
34. T.E. Meigs, M. Fedor-Chaiken, D.D. Kaplan, R. Brackenbury, and P.J. Casey G-12 and G-13 negatively regulate the adhesive functions of cadherin J Biol Chem 277 2002 24594 24600
35. I.H. Mills Kallikrein, kininogen and kinins in control of blood pressure Nephron 23 1979 61 71 (Pubitemid 9138133)
36. W. Neugebauer, P.A. Blais, S. Halle, C. Filteau, D. Regoli, and F. Gobeil Kinin B1 receptor antagonists with multi-enzymatic resistance properties Can J Physiol Pharmacol 80 2002 287 292 (Pubitemid 34451244)
37. A. Olejek, U. Mazurek, B. Michalski, D. Kusmierz, J. Orchel, and A. Witek Profiles of expression of genes coding kininogen and kinin receptors as a marker of tissue pathology in cervical cancer coexisting with HPV infection Wiadomości lekarskie 53 2000 247 254
38. J. Palermo-Neto, C.O. Massoco, and R.C. Favare Effects of maternal stress on anxiety levels, macrophage activity, and Ehrlich tumor growth Neurotoxicol Teratol 23 2001 497 507 (Pubitemid 33044566)
39. J. Palermo-Neto, C.O. Massoco, and W. Robespierre de Souza Effects of physical and psychological stressors on behavior, macrophage activity and Ehrlich tumor growth Brain Behav Immunol 17 2003 43 54 (Pubitemid 36207601)
40. M. Perretti, I. Appleton, L. Parente, and R.J. Flower Pharmacology of interleukin-1-induced neutrophil migration Agents Actions 38 1993 C64 C65
41. S.J. Perry, and R.J. Lefkowitz Arresting developments in heptahelical receptor signaling and regulation Trends Cell Biol 12 2002 130 138 (Pubitemid 34164652)
42. P.J. Pradelles, and J. Maclouf Enzyme immunoassays of eicosanoids using acetylcolinesterase as label: an alternative to radioimmunoassay Anal Chem 57 1985 1170 1173
43. D. Proud, A. Togias, R.M. Naclerio, S.A. Crush, P.S. Norman, and L.M. Lichtenstein Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen J Clin Invest 72 1983 1678 1685 (Pubitemid 14229047)
44. L.J.R.P. Raymundo, C.C. Guilhon, D.S. Alviano, M.E. Matheus, A.R. Antoniolli, and S.C.H. Cavalcanti Characterisation of the anti-inflammatory and antinociceptive activities of the Hyptis pectinata (L.) Poit essential oil J Ethnopharmacol 134 2011 725 732
45. D. Regoli, F. Marceau, and J. Barabé De novo formation of vascular receptors for bradykinin Can J Physiol Pharmacol 56 1978 674 677 (Pubitemid 8394605)
46. M. Rocha e Silva Chemical mediators of the acute inflammatory reaction Ann N Y Acad Sci 116 1964 899 911
47. P. Stern, A. Nikulin, and J. Fergula The role of histamine and bradykinin in the inflammatory process Arch Int Pharmacodyn Ther 140 1962 528 538
48. J.M. Stewart Bradykinin antagonists as anti-cancer agents Curr Pharm Des 9 2003 2036 2042 (Pubitemid 37139081)
49. J.M. Stewart, and L. Gera Bradykinin and cancer Handbook of biologically active peptides 2006 Elsevier 442 446
50. J.M. Stewart, L. Gera, D.C. Chan, E.J. York, V. Simkeviciene, and P.A. Bunn Jr. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists Peptides 26 2005 1288 1291 (Pubitemid 41021461)
51. J.M. Stewart, D.C. Chan, V. Simkeviciene, P.A. Bunn, B. Helfrich, and E.J. York Bradykinin antagonists as new drugs for prostate cancer Int Immunopharmacol 2 2002 1781 1786 (Pubitemid 35373921)
52. J.S. Taub, R. Guo, L.M. Leeb-Lundberg, J.F. Madden, and Y. Daaka Bradykinin receptor subtype 1 expression and function in prostate cancer Cancer Res 63 2003 2037 2041 (Pubitemid 36538604)
53. C.W. Tiffany, and R.M. Burch Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages FEBS Lett 247 1989 189 192 (Pubitemid 19129244)
54. H. Van Cauwenberge, N. Lisin, and R. Leclercq Phlogistic action of kallidin and its inhibition Semin Therapeutics 40 1964 190 192
55. P.C. Vincent, and A. Nicholls Comparision of the growth of the Ehrlich ascites tumor in male and female mice Cancer Res 27 1967 1058 1065
56. P.J. Woll, and E. Rozengurt Multiple neuropeptides mobilize calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin Biochem Biophys Res Commun 164 1989 66 73 (Pubitemid 19269696)
57. J. Wu, T. Akaike, T. Havashida, T. Okamoto, A. Okuvama, and H. Maeda Enhanced vascular permeability in solid tumors involving peroxynitrite and matrix metalloproteases Cancer Sci 92 2001 439 451 (Pubitemid 32427781)
58. J. Wu, T. Akaike, and H. Maeda Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor and a nitric oxide scavenger Cancer Res 58 1988 159 165